Search

everythinglearnresearchcommunity

for

Search:↓

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

Finasteride causes lasting fertility decrease in rats.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

No cure for female pattern hair loss, but various effective treatments exist.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Psychological stress and personal history are significant factors in hair loss.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

DNA methylation changes in women with PCOS could be used as disease markers and suggest new treatment targets.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Hair loss requires customized treatments based on its various causes and types.